Navigation Links
Medco Shareholders Approve Merger With Express Scripts
Date:12/21/2011

FRANKLIN LAKES, N.J., Dec. 21, 2011 /PRNewswire/ -- Shareholders of Medco Health Solutions, Inc. (NYSE: MHS) today approved a proposed merger with Express Scripts.

(Logo: http://photos.prnewswire.com/prnh/20100609/MEDCOLOGO)

With approximately 72 percent of the shares entitled to vote present in person or by proxy at a special meeting held today, shareholders adopted the Agreement and Plan of Merger dated July 20, 2011 by a margin of 99 percent to one percent, based on a preliminary tabulation.

In a non-binding advisory vote, shareholders also approved certain merger-related compensation arrangements for Medco's executive officers by a margin of 95 percent to five percent, based on a preliminary tabulation.

The merger is pending a parallel meeting of Express Scripts shareholders, required governmental consents, and other customary closing conditions.  Medco expects the merger transaction to close in the first half of 2012.

About Medco

Medco Health Solutions, Inc. (NYSE: MHS) is pioneering the world's most advanced pharmacy® and its clinical research and innovations are part of Medco making medicine smarter™ for more than 65 million members.

With more than 20,000 employees dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2010 revenues of $66 billion, Medco ranks 34th on the 2011 Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy companies. 

For more information, go to http://www.medcohealth.com

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.       

 


'/>"/>
SOURCE Medco Health Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Combining Express Scripts and Medco Health Solutions Will Help Protect Americans From the Rising Costs of Prescription Medicine
2. Express Scripts and Medco Save Americans Tens of Billions in Healthcare Costs, New Economic Report Shows
3. National Coalition Continues Fight to Stop the Express Scripts/Medco Merger in Nations Capitol
4. Medco Research Institute Study Shows Some Patients Discontinue New Anticoagulant Drug Early, Which May Increase Stroke Risk
5. Nationwide Coalition Joins Reps. Courtney & Marino Outside U.S. Capitol To Oppose Express Scripts/Medco Merger
6. Lawmakers, Pharmacists Rally Against Express Scripts-Medco Merger Proposal at U.S. Capitol
7. Nationwide Coalition Issues Call To Action To Stop Express Scripts/Medco Merger
8. Nationwide Coalition Opposes Express Scripts/Medco Merger
9. Medco, Quest Diagnostics Personalized Medicine Study Yields Additional Clues about Patient Engagement
10. Medco Wins 2011 URAC Award for Best Practices in Health Care Consumer Empowerment and Protection
11. Merger of Express Scripts and Medco Health Solutions Will Address the Bipartisan Mandate for Safer, More Affordable, Higher Quality Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... , Dec. 6, 2016  Viking Therapeutics, ... clinical-stage biopharmaceutical company focused on the development of ... announced that the U.S. Food and Drug Administration ... for the treatment of X-linked adrenoleukodystrophy (X-ALD).  VK0214 ... (TRß) agonist that selectively regulates the expression of ...
(Date:12/6/2016)... , Dec. 6, 2016 A new study ... of 340B (AIR 340B) projects the 340B Drug Pricing Program ... by which time it is expected to exceed $23 billion ... would see 340B purchases surpass current Medicare Part B drug ... The new study – based on analysis of data on ...
(Date:12/6/2016)... , Dec. 6, 2016  BioAtla, LLC, ... development of Conditionally Active Biologic (CAB) antibody ... Sinobioway Group Company, Limited (Sinobioway) selected their ... The specific program candidates and the targeted ... BioAtla and Sinobioway entered into a strategic ...
Breaking Medicine Technology:
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... ... the launch of a Kickstarter crowd funding campaign ( http://kck.st/2g3a1so ) for the ... active alerts and even taking an EKG from the watch while sharing these ...
(Date:12/6/2016)... CA (PRWEB) , ... December 06, 2016 , ... 'Tis ... can disrupt daily routines. That means it's also the season when eating healthy, staying ... living with diabetes) on schedule is harder to do. , "Shopping trips, parties ...
(Date:12/6/2016)... ... December 06, 2016 , ... “Tatiana Sibirskaya: A Life ... story of sacrifice and enlightenment. , “Tatiana Sibirskaya: A Life Devoted ... looking for creative outlets, Carolyn gravitated toward writing through the inspiration of her ...
(Date:12/6/2016)... ... 06, 2016 , ... TopConsumerReviews.com recently gave a best-in-class 5 star rating to ... give freedom to people who need help getting around. For some, advancing age has ... period of rehabilitation after an illness or accident. There is a wide variety of ...
(Date:12/6/2016)... ... December 06, 2016 , ... "Add realistic flares and light leaks to ... from clip to clip with high quality 4K lens flare footage," said Christina Austin ... lens flares filmed on the RED Dragon. Utilizing the Dragon Sensor, TransFlare 4K Jewel ...
Breaking Medicine News(10 mins):